相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Immunotherapy for urothelial cancer: from BCG to checkpoint inhibitors and beyond
Yin Wu et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2015)
Prognostic and predictive factors in patients treated with chemotherapy for advanced urothelial cancer: where do we stand?
Sebastiano Buti et al.
FUTURE ONCOLOGY (2015)
Epithelial to mesenchymal transition is associated with rapamycin resistance
Ashley M. Holder et al.
ONCOTARGET (2015)
Acetazolamide triggers death inducing autophagy in T-47D breast cancer cells
Raziye Mohammadpour et al.
CELL BIOLOGY INTERNATIONAL (2014)
Combination of carbonic anhydrase inhibitor, acetazolamide, and sulforaphane, reduces the viability and growth of bronchial carcinoid cell lines
Reza Bayat Mokhtari et al.
BMC CANCER (2013)
Overexpression of Rab25 contributes to metastasis of bladder cancer through induction of epithelialmesenchymal transition and activation of Akt/GSK-3/Snail signaling
Jiaxing Zhang et al.
CARCINOGENESIS (2013)
Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche
F. E. Lock et al.
ONCOGENE (2013)
Emerging therapies for urothelial cancer
Cesar Serrano et al.
CANCER TREATMENT REVIEWS (2012)
Inhibition of bladder cancer by broccoli isothiocyanates sulforaphane and erucin: Characterization, metabolism, and interconversion
Besma Abbaoui et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2012)
Effects of mTOR Inhibitor Everolimus (RAD001) on Bladder Cancer Cells
Edmund Chiong et al.
CLINICAL CANCER RESEARCH (2011)
Targeting renal cell carcinoma with NVP-BEZ235, a dual PI3K/mTOR inhibitor, in combination with sorafenib
Didier Roulin et al.
MOLECULAR CANCER (2011)
Synergistic Activity of Sorafenib and Sulforaphane Abolishes Pancreatic Cancer Stem Cell Characteristics
Vanessa Rausch et al.
CANCER RESEARCH (2010)
Sulforaphane inhibits 4-aminobiphenyl-induced DNA damage in bladder cells and tissues
Yi Ding et al.
CARCINOGENESIS (2010)
Expanding therapeutic targets in bladder cancer: the PI3K/Akt/mTOR pathway
Christina Barbara Ching et al.
LABORATORY INVESTIGATION (2010)
Combination Treatment with Resveratrol and Sulforaphane Induces Apoptosis in Human U251 Glioma Cells
Hao Jiang et al.
NEUROCHEMICAL RESEARCH (2010)
Molecular Targeting of Carbonic Anhydrase IX in Mice with Hypoxic HT29 Colorectal Tumor Xenografts
Sean Carlin et al.
PLOS ONE (2010)
Anticancer Activity of a Broccoli Derivative, Sulforaphane, in Barrett Adenocarcinoma: Potential Use in Chemoprevention and as Adjuvant in Chemotherapy
Aamer Qazi et al.
TRANSLATIONAL ONCOLOGY (2010)
Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer
David J. McConkey et al.
CANCER AND METASTASIS REVIEWS (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Synergistic Inhibitory Effect of Sulforaphane and 5-Fluorouracil in High and Low Metastasis Cell Lines of Salivary Gland Adenoid Cystic Carcinoma
Xiao-Feng Wang et al.
PHYTOTHERAPY RESEARCH (2009)
Novel therapeutics in metastatic bladder cancer
Alexandros Lekas et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Nrf2 activation by sulforaphane restores the age-related decrease of TH1 immunity:: Role of dendritic cells
Hyon-Jeen Kim et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
Sauveur-Michel Maira et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55 years of age
Ivar Skaland et al.
MODERN PATHOLOGY (2007)
Hypoxia-driven selection of the metastatic phenotype
Richard Sullivan et al.
CANCER AND METASTASIS REVIEWS (2007)
Sulforaphane as a promising molecule for fighting cancer
Carmela Fimognari et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2007)
Antiproliferative activity of sulforaphane in Akt-overexpressing ovarian cancer cells
Devyani Chaudhuri et al.
MOLECULAR CANCER THERAPEUTICS (2007)
New molecular targets and novel agents in the treatment of advanced urothelial cancer
Kathleen W. Beekman et al.
SEMINARS IN ONCOLOGY (2007)
Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease
Vitaly Margulis et al.
CLINICAL CANCER RESEARCH (2006)
Potent activation of mitochondria-mediated apoptosis and arrest in S and M phases of cancer cells by a broccoli sprout extract
L Tang et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Chemoprotection by sulforaphane: Keep one eye beyond Keap1
MC Myzak et al.
CANCER LETTERS (2006)
Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis
Jason J. Christiansen et al.
CANCER RESEARCH (2006)
Role of PI3K/Akt and MEK/ERK signaling pathways in sulforaphane- and erucin-induced phase II enzymes and MRP2 transcription, G2/M arrest and cell death in Caco-2 cells
J Jakubíková et al.
BIOCHEMICAL PHARMACOLOGY (2005)
The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria
T Ribalta et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer
KJ Turner et al.
BRITISH JOURNAL OF CANCER (2002)
Induction and regulation of epithelial-mesenchymal transitions
B Boyer et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro
S Parkkila et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
